We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.71%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.3B
AUM Growth
-$783M
(-2.3%)
Cap. Flow
-$715M
Cap. Flow
% of AUM
-2.15%
Top 10 Holdings %
Top 10 Hldgs %
15.9%
Holding
3,039
New
28
Increased
1,056
Reduced
1,268
Closed
57
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$29M |
| 2 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$14M |
| 3 |
Microsoft
MSFT
|
+$10.8M |
| 4 |
Meta Platforms (Facebook)
META
|
+$10.5M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$6.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$34.4M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
+$32.2M |
| 3 |
ExxonMobil
XOM
|
+$23.9M |
| 4 |
Warner Bros
WBD
|
+$15.4M |
| 5 |
RTX Corp
RTX
|
+$13.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.81% |
| 2 | Financials | 14.8% |
| 3 | Healthcare | 13.73% |
| 4 | Industrials | 10.72% |
| 5 | Energy | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Cimpress
CMPR
$2.39B
| $1.67M | 0.01% |
30,428
-85
| -0.3% | -$3.88K |
|
|
AKS
1452
DELISTED
AK Steel Holding Corp
AKS
| $1.67M | 0.01% |
208,174
+6,756
| +3% | +$62.9K |
|
1453
Sinclair Inc
SBGI
$992M
| $1.67M | 0.01% |
63,838
-1,085
| -2% | -$33.3K |
|
1454
U-Haul Holding Co
UHAL
$13.9B
| $1.66M | 0.01% |
63,520
+500
| +0.8% | +$13.8K |
|
|
TRLA
1455
DELISTED
TRULIA INC (DEL)
TRLA
| $1.65M | 0.01% |
33,801
+550
| +2% | +$29.5K |
|
|
SYNT
1456
DELISTED
Syntel Inc
SYNT
| $1.65M | 0.01% |
37,566
+200
| +0.5% | +$8.81K |
|
1457
Molina Healthcare
MOH
$10.2B
| $1.65M | 0.01% |
38,996
+1,145
| +3% | +$50.7K |
|
|
ISCA
1458
DELISTED
International Speedway Corp
ISCA
| $1.65M | ﹤0.01% |
52,035
+60
| +0.1% | +$1.93K |
|
1459
Integer Holdings
ITGR
$4.12B
| $1.64M | ﹤0.01% |
42,306
+373
| +0.9% | +$15.9K |
|
1460
Virtus Investment Partners
VRTS
$1.06B
| $1.64M | ﹤0.01% |
9,445
+64
| +0.7% | +$13K |
|
|
CYS
1461
DELISTED
CYS Investments Inc.
CYS
| $1.64M | ﹤0.01% |
199,069
+600
| +0.3% | +$5.41K |
|
|
ACOR
1462
DELISTED
Acorda Therapeutics
ACOR
| $1.64M | ﹤0.01% |
403
-11
| -3% | -$41.3K |
|
|
VSI
1463
DELISTED
Vitamin Shoppe Inc.
VSI
| $1.64M | ﹤0.01% |
36,845
+180
| +0.5% | +$7.55K |
|
1464
AAR Corp
AIR
$5.59B
| $1.63M | ﹤0.01% |
67,637
-100
| -0.1% | -$2.71K |
|
|
CVA
1465
DELISTED
Covanta Holding Corporation
CVA
| $1.63M | ﹤0.01% |
76,950
-2,275
| -3% | -$47.4K |
|
1466
Provident Financial Services
PFS
$3.22B
| $1.63M | ﹤0.01% |
99,507
+150
| +0.2% | +$2.54K |
|
|
HT
1467
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $1.62M | ﹤0.01% |
63,728
-150
| -0.2% | -$4.03K |
|
1468
Banco Santander
SAN
$201B
| $1.62M | ﹤0.01% |
188,006
+3,760
| +2% | +$33.9K |
|
|
PMCS
1469
DELISTED
P M C SIERRA INC
PMCS
| $1.62M | ﹤0.01% |
217,266
| – | – |
|
|
CAA
1470
DELISTED
CalAtlantic Group, Inc.
CAA
| $1.61M | ﹤0.01% |
43,092
+570
| +1% | +$22.9K |
|
|
MAGN
1471
Magnera Corp
MAGN
$472M
| $1.61M | ﹤0.01% |
5,648
+23
| +0.4% | +$7.33K |
|
|
IGTE
1472
DELISTED
IGATE CORPORATION
IGTE
| $1.61M | ﹤0.01% |
43,896
+1,320
| +3% | +$49.1K |
|
|
EXPR
1473
DELISTED
Express, Inc.
EXPR
| $1.61M | ﹤0.01% |
5,156
-12
| -0.2% | -$3.82K |
|
1474
Caleres
CAL
$431M
| $1.6M | ﹤0.01% |
59,163
+250
| +0.4% | +$7.22K |
|
|
SHLM
1475
DELISTED
Schulman (A.) Inc
SHLM
| $1.6M | ﹤0.01% |
44,374
+293
| +0.7% | +$11.6K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2014 Portfolio in Review
As of Q3 2014, RhumbLine Advisers held 3,039 positions worth $33.3B, down 2.3% from $34.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q3 2014: portfolio turnover was 2.8%. RhumbLine Advisers opened 28 new positions and exited 57, leaving the 3,039-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 346,925 shares worth $12.9M.
- RhumbLine Advisers added most to Allergan plc in Q3 2014, an estimated $29M increase.
- RhumbLine Advisers's biggest Q3 2014 reduction was Apple, cutting an estimated $34.4M.
- RhumbLine Advisers fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $32.2M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $33.3B portfolio in Q3 2014.
- RhumbLine Advisers opened 28 new positions and closed 57 in Q3 2014.
- RhumbLine Advisers's portfolio value fell 2.3% quarter-over-quarter to $33.3B.
Based on RhumbLine Advisers's 13F filing for Q3 2014, filed 12 Nov 2014.